Search

The Corporate Transparency Act (CTA) imposes significant new reporting requirements on many small businesses, as of January 1, 2024. The law requires all “reporting companies” to identify their “beneficial owners” and “company applicants” in a report to be filed with the U.S. Treasury Department’s...

As the U.S. seeks to jumpstart a hydrogen economy with the creation of Regional Clean Hydrogen Hubs (H2Hubs), Saul Ewing stands ready to advise clients in the energy, transportation, industrial, manufacturing and agribusiness industries on next steps. The H2Hubs will accelerate the commercial-scale...

With a rapid pace of adoption, artificial intelligence (AI) platforms and applications are becoming widespread in nearly every industry. While these tools unlock great potential, their unchecked use presents many challenges. For example, employees without adequate training could be entering...

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

Responsive Service and Real-World Guidance Attorneys in Saul Ewing's Financial Services Practice advise and represent local, community and regional banks; credit unions; and other private and public finance entities in a wide range of transactional and business matters. We provide practical legal...

Navigating Complex Regulations and Risks The federal government (Government) imposes unique requirements on entities that sell, directly or indirectly, goods or services to the Government. These requirements vary according to type of contract (e.g., fixed-price, cost-reimbursement), by item (e.g...

Protecting the Rights of Corporate Clients Companies generally enjoy a fruitful relationship with their shareholders, but disagreements about management, perceptions of minority shareholder mistreatment, or concerns over executive compensation may arise. No matter the cause of shareholder...

A key component of a company’s intellectual property strategy is the protection of its industrial designs, including the ornamental features of products, graphical user interfaces, icons and fonts, to combat competitors copying its products. Industrial design protection fills a niche between (and...

Handling the Challenges of a Rapidly Evolving Industry From the rise of smart cities and 5G to blockchain and machine-to-machine communication, next generation wireless technologies are reshaping our world. Participants in the telecommunications and digital infrastructure industry have a critical...

Saul Ewing attorneys have significant experience advising a wide variety of clients in the entertainment, music, visual and performing arts industries. Our clients include artists, writers, musicians, models, film, and multi-media production companies, record labels, producers, merchandisers...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

An Experienced Legal Team for the Entire Life Cycle of a Fund The complexities of forming and managing an investment fund are vast and varied — from changing market trends and investment strategies, to shifting tax and regulatory requirements. Navigating this landscape while maximizing return on...

Guidance Throughout a Shifting Global Landscape Growth and opportunity are driving factors for success in today’s expanding global economy. The prevalence of crossing borders to gain a competitive edge, sustain profitability, maximize investments or realize personal goals has resulted in a critical...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

Congressional investigations present these significant risks for individuals and organizations: investigations often arise suddenly and under the harsh glare of media attention investigators often make wide-ranging demands for documents and testimony timelines can be rapid and hard to predict...

Saul Ewing attorneys counsel boards on both the routine and extraordinary decisions they encounter. We advise public company boards with respect to exchange and federal securities rules. We counsel on: Fiduciary and financial reporting responsibilities Board policies, procedures, governance and...

Debt financing can be an invaluable resource for borrowers when capital is required to fund the needs of a company or an organization that is unable or unwilling to sell equity. Lenders strive to serve the needs of their borrower clients while safeguarding their own interests and ultimately ensuring...

Saul Ewing attorneys provide legal opinions in connection with complex business, financing and real estate transactions involving corporations, limited liability companies (LLCs), limited partnerships (LPs), real estate investment trusts (REITs), statutory and business trusts, and nonprofits. We...

In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...

Saul Ewing’s Shareholder Litigation Practice is national, but we have substantial strength in Maryland. It is the second most popular state of incorporation for companies listed on the New York Stock Exchange and the state in which more than 80 percent of all publicly registered REITs are formed...